Author

P. Murer

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 3 Approach:experimental assay· 3 Organism:mouse· 3 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

D. Neri· 3 shared M. Stringhini· 2 shared A. Villa· 1 shared B. Gouyou· 1 shared C. Hutmacher· 1 shared E. Puca· 1 shared G. Pellegrini· 1 shared J. Mock· 1 shared

Activity by Year

2019-2020 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

D. Neri

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Antibody-mediated delivery of LIGHT to the tumor boosts Natural Killer cells and delays tumor progression

M. Stringhini, J. Mock, V. Fontana, P. Murer, D. Neri

This paper develops a LIGHT-based fusion protein that accumulates in tumors and enhances Natural Killer cell activity, slowing tumor growth in mouse models.

bioRxiv · May 8, 2020Immunology

A novel human monoclonal antibody specific to the A33 glycoprotein recognizes colorectal cancer and inhibits metastasis

P. Murer, L. Pluess, D. Neri

This study develops a human monoclonal antibody targeting A33, showing efficacy in inhibiting colorectal cancer metastasis in vivo.

bioRxiv · Aug 28, 2019Pharmacology & Toxicology

The antibody-based delivery of interleukin-12 to solid tumors boosts NK and CD8+ T cell activity and synergizes with immune check-point inhibitors

E. Puca, P. Probst, M. Stringhini, P. Murer, G. Pellegrini, S. Cazzamalli, C. Hutmacher, B. Gouyou, S. Wulhfard, M. Matasci, A. Villa, D. Neri

This paper describes a fusion protein that delivers interleukin-12 to tumors, enhancing NK and CD8+ T cell activity and synergizing with checkpoint inhibitors.

bioRxiv · Jul 3, 2019Cancer Biology